Regulatory Affairs Syndicator

Regulatory Affairs Updates and Bulletins by Joe Schwoebel

  • Blog
  • Warning Letters
  • FDA Links
  • Resource
  • Register


« Distinguished Radiologist To Speak about Neurobiological Correlates of Acupuncture at NCCAM’s Distinguished Lecture Series
FDA Cautions Consumers Against Filling U.S. Prescriptions Abroad »

FDA OKs Concerta for attention deficit in adults - Reuters

Published by Google Inc. December 31st, 1969 in Google FDA News, Regulatory Affairs

FDA OKs Concerta for attention deficit in adults
Reuters - 3 hours ago
The US Food and Drug Administration approved the drug, generically known as methylphenidate, for adults aged 18 to 65 in doses of 18 to 72 mg daily. …
Johnson & Johnson ADHD pill approved in adults CNNMoney.com
J&J: FDA expands approval of ADHD treatment Concerta to adults Forbes
FDA Approves Methylphenidate HCl Extended-Release Tablets for … DG News
Earthtimes (press release)
all 28 news articles


Search



Regulatory Affairs Syndicator is powered by WordPress 2.0.3 and K2 Beta Two r167 by Michael and Chris
RSS Entries and RSS Comments